GHB04L1
GHB-CS03
Phase 1 mab completed
Quick answer
GHB04L1 for Influenza is a Phase 1 program (mab) at Atea Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Atea Pharmaceuticals
- Indication
- Influenza
- Phase
- Phase 1
- Modality
- mab
- Status
- completed